IPLS Previous Events

Our events are a hub for life-science networking, building  relationships and helping you seal international deals to grow your business.


‘Bright Here, Right Now’

26 – 28 September 2022

IPLS Brighton, the return to face-to-face IPLS events, took place in Brighton, UK, from Monday 26 to Wednesday 28 September 2022.

IPLS Brighton in numbers:

  • over 225 participants attended the event
  • 796 confirmed one-to-partnering meetings 
  • 16 presentations
  • 3 panel discussions
  • 2 flights aboard British Airways i360 during networking drinks reception & dinner on Tuesday evening

Attendees can access PDF copies of approved presentation HERE


Life-Sciences BD&L in 2021

30 September & 1 October 2021

The IPLS Online Pitch & Partner 2 day event took place on Thursday 30 September & Friday 1 October 2021. 

DAY ONE – Pitch: involved short ‘pitch’ presentations from companies that have innovative products or technologies available for Business Development

DAY TWO – Partner: one to one online partnering meetings, each lasting up to 30 minutes



Invitation to Italy HLG Pitch & Partner – 26th March 2021

We are pleased to invite you to our Pitch & Partner online event which takes place on Friday, 26th March and will be held in English. 

The morning consists of 9 x 15 minute ‘Pitch’ presentations, followed by an afternoon of pre-arranged partnering meetings. The invitation was extended to IPLS colleagues.

IPLS Online

Due to this years Covid 19 Crisis part one of our Annual conference was staged online

The 16th IPLS Annual meeting will now take place in two parts.

Part 1 to be hosted online 16th-17th September 2020
Part 2 in Brighton England 15th-17th September 2021


Pre CPHI Meeting

As the world life science community meets at the CPhI in Milan, the IPLS will be hosting a networking drinks reception the night before the event. A great opportunity to catch up with friends and colleagues

12th October 2020 Milan, Italy

Disruption or Evolution?

Contemporary Trends in Pharma Business Development

Pullman Paris Centre

Paris, France

Conference Programme

  • Contemporary trends in pharma business development
  • Aging and age-related diseases
  • Discovery & development of disease-modifying drugs
  • New therapeutics for diseases of aging
  • Artificial Intelligence; Debunk the myths; How can AI impact deal making in Life Sciences?
  • Evolution of organizational structures and BD teams
  • The pathology of aging challenges and opportunities
  • From Flower to Pharma Power?

Hosted by PLCF

Pre CPHI Anglo-Canadian-French Networking Evening

Steigenberger Frankfurter Hof

Frankfurt, Germany

Hosted by PLCF, PLG and Canadian Healthcare Licensing association (CHLA)

Peak Performance

Evolve your Deals

Fairmont Le Montreux Palace

Montreux, Switzerland

Conference Programme

  • New Opportunities for Business Development in a Changing World
  • The Regulatory & Market Access Environment and The Impact on Business Development
  • Lessons from Real World Case Studies
  • Analysing the Hottest Deal Environment and New Dynamics
  • Back to the Future: How Can We Build a Future Without Losing Our Past?

Hosted by Swiss HLG


The Role of Business Development in Changing Global Times

NH Collection Madrid Eurobuilding

Madrid, Spain

Conference Programme

  • External Factors Impacting the Pharmaceutical Industry
  • The Impact of Digital Technology
  • The Increasing Important of the OTC and Other Business Areas
  • Risk or Opportunity? IP & Market Access
  • Financial Evaluation & Business Models

Hosted by PLGS

New Health Economy and its Impact on Deal Making

Radisson Blu, Royal Hotel

Brussels, Belgium

Conference Programme

  • Strategic Issues
  • Deal Finances & Valuation
  • Biosimilars/Generics
  • European Market Access
  • Patient Centricity / Digital Health

The Disappearing Deal World?

How Companies Secure Deals in an Environment of Big Pharma M&A and Strategic Alliances

Hilton Berlin

Berlin, Germany

Conference Programme

  • Deal Environment Reviews Across the Healthcare Sector and How M&A is Affecting Their Business
  • Consolidation and Risk Sharing Between Big Pharma Companies
  • Impact of the Changing Deal Environment for Mid-Sized Companies
  • Challenges Securing Deals in Other Countries
  • Business Models Proving Resistant to Pharma M&A

Hosted by PLCD

Sink or Swim in Europe: The Role of Business Development

Hilton Prague Old Town

Prague, Czech republic

Conference Programme

  • Emerging Markets
  • New Business Models
  • European Entry Strategy
  • Deal Issues
  • Orphan Drugs
  • Local Emerging / Existing Market Issues

Hosted by PLG CEE



Business Development: From Molecule to Market….and Beyond

Dublin, Republic of Ireland

Conference Programme

  • Future Challenges
  • Innovation – the Engine for Growth via Early Stage Licensing
  • Innovation – the Engine for Growth via Mid Stage Licensing
  • Life Cycle Management – Maximising Value Throughout the Product Lifecycle
  • World Outreach
  • Future Trends
  • Financing Deals

Hosted by PLG UK

Success Factors for Licensing

Budapest, Hungary

Conference Programme

  • Closing Regional Deals
  • Finding New Products
  • How do Multinationals do BD?
  • BD in the OTC World
  • Emerging Markets
  • Post Patent Cliff
  • Recent Development in SPC’s
  • Biosimilar Development Strategy
  • Pricing and Reimbursement in a Changing EU Healthcare Environment

Business Development in Challenging Times – a Growth Area in a Contracting Industry

Barcelona, Spain

Conference Programme

  • Clinical Relevance in Partnering
  • As Pharma Withdraws from R&D a Golden Age for BD Begins
  • Fight or Flight – is Diversification Pharma’s New Business Model?
  • Partnering Issues
  • Mid Cap Company Strategies
  • Personalised Medicine
  • Specialities – the New Growth Area?
  • Drug Delivery- New Smart Pill Technologies
  • Market Access Strategies
  • Biotech
  • Market Issues

Business Opportunities and Comprehensive Healthcare

Vienna, Austria

Conference Programme

  • Vaccines
  • Pharma Looking Inwards and Outwards
  • Anti-infectives
  • Medicines for Third World Diseases
  • BD in CEE Countries
  • Healthcare in Emerging Markets
  • R&D in Developing Countries
  • Biosimilars versus Biobetters
  • Big Pharma Finally Warms to Generic Pariahs
  • Cultural Issues in Negotiation
  • Strategies at the Edge of Patent Life
  • Changing Landscapes in Drug Delivery
  • Sources of Funding
  • Partnering Trends in Europe
  • European Price Reductions and the Impact on Royalties